Abstract
A high potency of Lycopodium clavatum Linn. (200th centesimal potency) is tested for its hepatoprotective action against
carbon tetrachloride-induced hepatic damage in rat. It has been established from biochemical
and histopathological studies that at least 4 doses of Lycopodium 200 can control the CCl4-induced alteration of plasma levels of aspartate aminotransferase, alanine aminotransferase,
alkaline phosphatase, acetylcholinesterase, lactate deyhydrogenase, bilirubin and
urea. Protective action of the drug has also been confirmed by microanatomical studies
on hepatic tissues.